AbbVie Inc. - 8-K Filing
AbbVie director Jennifer L. Davis to resign effective November 2, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Offic)
Tickers: $ABBV
Read the full article at SEC EDGAR
Part of the story TriplePoint Venture Growth BDC Corp. - 8-K Filing (197 articles)